Laurence Cohen

Laurence Cohen is currently the Regional Director of Onco-Hematology at Amgen, where they oversee the development of six franchises in oncology and hematology, manage a team of nine scientific liaisons, and have been responsible for the launch of Carfilzomib and other treatments. Prior to this role, Laurence served as a Scientific Liaison at Amgen from 2001 to 2007 and worked as a Hospital Delegate at AstraZeneca from 1994 to 2000. Laurence holds a degree in Marketing and Communication from ICD GROUPE IGS, obtained between 1988 and 1992.